CL
ENZN

CSS LLC’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

CSS LLC’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-92,572
Closed -$44K – 791
2016
Q1 		$44K Sell
92,572
-4,000
-4% -$1.95K ﹤0.01% 632
2015
Q4 		$66K Sell
96,572
-62,257
-39% -$49.4K ﹤0.01% 648
2015
Q3 		$154K Hold
158,829
– – 0.01% 621
2015
Q2 		$191K Hold
158,829
– – 0.01% 669
2015
Q1 		$168K Hold
158,829
– – 0.01% 634
2014
Q4 		$173K Sell
158,829
-38,350
-19% -$40.2K 0.01% 658
2014
Q3 		$213K Hold
197,179
– – 0.01% 651
2014
Q2 		$205K Hold
197,179
– – 0.01% 642
2014
Q1 		$203K Hold
197,179
– – 0.01% 567
2013
Q4 		$229K Buy
+197,179
New +$304K 0.01% 543

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

CSS LLC's ENZN Position: Q2 2016 in Review

CSS LLC sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 92,572 shares — an estimated $44K sold.

CSS LLC first reported a position in ENZN in Q4 2013 and held it in 10 quarters. The position peaked at $229K in Q4 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • CSS LLC reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • CSS LLC sold 92,572 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $44K.
  • CSS LLC first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 10 quarters.
  • CSS LLC's ENZON PHARMACEUTICALS INC position peaked at $229K in Q4 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on CSS LLC's 13F filing for Q2 2016, filed 15 Aug 2016.